Fasenra Prescribing Information
5.3 Reduction of Corticosteroid Dosage Do not discontinue systemic or inhaled corticosteroids abruptly upon initiation of therapy with FASENRA. Reductions in corticosteroid dose, if appropriate, should be gradual and performed under the direct supervision of …
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Documents from same domain
SYMBICORT Medication Guide
den8dhaj6zs0e.cloudfront.netSYMBICORT comes in 2 strengths. Your healthcare provider has prescribed the strength that is best for you. Note the differences between SYMBICORT and your other inhaled medications, including the differences in prescribed use and physical appearance.
Imfinzi Full Prescribing Information
den8dhaj6zs0e.cloudfront.netlung cancer (NSCLC) whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy. (1.1) • in combination with etoposide and either carboplatin or cisplatin, as first-line treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC). (1.2)
Lynparza Prescribing Information
den8dhaj6zs0e.cloudfront.net5.4 Venous Thromboembolic Events 6 ADVERSE REACTIONS 6.1 Clinical Trial Experience 6.2 Postmarketing Experience 7 DRUG INTERACTIONS 7.1 Use with Anticancer Agents 7.2 Effect of Other Drugs on Lynparza 8 USE IN SPECIFIC POPULATIONS 8.1 Pregnancy 8.2 Lactation 8.3 Females and Males of Reproductive Potential 8.5 Geriatric Use 8.6 Renal Impairment
Information, Prescribing, Pregnancy, Prescribing information, Thromboembolic
BREZTRI Full Prescribing Information
den8dhaj6zs0e.cloudfront.netIf the inhaler has not been used for more than 7 days, is dropped, or after weekly . cleaning, prime the inhaler again by releasing 2 sprays into the air away from the face, shaking well before each spray. 2.3 Dose counter. BREZTRI AEROSPHERE canister has an attached dose indicator, which indicates . how many inhalations remain.
Information, Prescribing, Dose, Prescribing information, Inhaler
SYMBICORT Prescribing Information
den8dhaj6zs0e.cloudfront.net5.18 Hypokalemia and Hyperglycemia. 6 ADVERSE REACTIONS. 6.1 Clinical Trials Experience in Asthma 6.2 Clinical Trials Experience in Chronic Obstructive Pulmonary Disease. 6.3 Postmarketing Experience. 7 DRUG INTERACTIONS. Antidepressants 7.3 Beta-Adrenergic Receptor Blocking Agents 7.4 Diuretics. 8 USE IN SPECIFIC POPULATIONS. 8.1 Pregnancy …
US-56427 ---------------------------- DOSAGE AND ...
den8dhaj6zs0e.cloudfront.netnot start BRILINTA in patients undergoing urgent coronary artery bypass graft surgery (CABG). (5.1, 6.1) • If: possible, manage bleeding without discontinuing ----- BRILINTA. Stopping BRILINTA increases the risk of subsequent cardiovascular events. (5.4) ASPIRIN DOSE AND BRILINTA EFFECTIVENESS IN PATIENTS WITH ACS ...
Farxiga Prescribing Information
den8dhaj6zs0e.cloudfront.netpatients with polycystic kidney disease or patients requiring or with a recent . history of immunosuppressive therapy for the treatment of kidney disease. FARXIGA is not expected to be effective in these populations. (1)----- DOSAGE AND ADMINISTRATION ----- • Assess volume status and correct volume depletion before initiating. ...
Information, Disease, Prescribing, Kidney, Prescribing information, Kidney disease, Polycystic, Polycystic kidney disease
FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE ...
den8dhaj6zs0e.cloudfront.netHealthcare Providers for detail on preparation and administration. (2) ... registered nurses, and physician assistants that are licensed or authorized under state law to prescribe drugs in the therapeutic class to which EVUSHELD belongs (i.e., anti-infectives).
CRESTOR PRESCRIBING INFORMATION
den8dhaj6zs0e.cloudfront.netreduce elevated total-C, LDL-C, ApoB, nonHDL-C, and TG levels and to increase HDL-C (1.1) ... Monitor INR frequently until stable upon initiation or alteration of CRESTOR therapy. (5.4, 7.6) • Concomitant lipid-lowering therapies: Use with fibrates or lipid-modifying doses (≥1 g/day)
Saphnelo full Prescribing Information
den8dhaj6zs0e.cloudfront.netwith severe active lupus nephritis or severe active central nervous system lupus. Use . of SAPHNELO is not recommended in these situations. (1)----- DOSAGE AND ADMINISTRATION -----The recommended dosage is 300 mg as an intravenous infusion over a 30-minute . …
Related documents
What Is Allergic Bronchopulmonary Aspergillosis (ABPA)?
www.thoracic.orgThe corticosteroid (steroid medicine) is used to treat inflammation and blocks the allergic reaction. Examples . of corticosteroids include: prednisone, prednisolone or methylprednisolone. Inhaled corticosteroids alone— such as used for asthma treatment—are not effective in treating ABPA. Usually treatment with an oral
ARNUITY ELLIPTA (fluticasone furoate inhalation powder)
gskpro.coman inhaled corticosteroid (ICS) is 100 mcg. For other adults and adolescents aged 12 years and older, the starting dose should be based on previous asthma drug therapy and disease severity. For adults and adolescents aged 12 years and older who do not respond to ARNUITY ELLIPTA